Research

The Key to Commercializing Revolutionary Gene Therapiesand Other Orphan Drugs

October 27, 2022

The Key
In today’s evolving, value-based environment for specialty drugs, hightouch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery

Spotlight

Pharma D&S

Pharma D&S was born in 2001 as service company for the pharmaceutical and lifescience field through the activity of executive managers coming from various business areas where they held important managerial positions at corporate level in various company sectors. Throughout their working experience, these professionals felt the growing need of the sector for reliable, efficient and really skilful service providers. This need arises from the company necessity to focus the internal resources on the core business; in addition, the availability of qualified suppliers allows to create a team integrated with the mandant company personnel, thus providing, in the same time, services and opportunities of professional growth for the involved resources.

OTHER WHITEPAPERS
news image

New Active Substances Launched During 2021

whitePaper | June 27, 2022

Following on from our review of trends in the current pharmaceutical R&D pipeline this supplement takes a look at the industry’s success stories of 2021

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More
news image

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis

whitePaper | June 28, 2022

CF is a rare, autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene that encodes the CFTR protein, an anion channel normally present in the epithelial membrane.1,2

Read More
news image

Pharma R&D Annual Review 2022 Navigating the Landscape

whitePaper | May 7, 2022

Citeline, Welcome to Pharmaprojects' 2022 reviews of trends in pharmaceutical R&D. Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

Read More
news image

The true impact of machine failure in pharma

whitePaper | November 24, 2022

Today’s pharmaceutical industry is facing big expectations and opportunities. Tasked with developing and manufacturing effective therapeutics and vaccines for an ongoing global pandemic,

Read More
news image

Potential measures to facilitate the productions of activepharmaceutical ingredients (APIs)

whitePaper | March 27, 2023

European countries have been experiencing medicine shortages due to disruptions in the supply chain. Reshoring the productions of active pharmaceutical ingredients (APIs) is considered as an approach to secure the supply.

Read More

Spotlight

Pharma D&S

Pharma D&S was born in 2001 as service company for the pharmaceutical and lifescience field through the activity of executive managers coming from various business areas where they held important managerial positions at corporate level in various company sectors. Throughout their working experience, these professionals felt the growing need of the sector for reliable, efficient and really skilful service providers. This need arises from the company necessity to focus the internal resources on the core business; in addition, the availability of qualified suppliers allows to create a team integrated with the mandant company personnel, thus providing, in the same time, services and opportunities of professional growth for the involved resources.

Events